Status:
COMPLETED
The Effect Of Blood Flow Restrıcted Resistive And Aerobic Exercises in Chronic Obstructive Pulmonary Patients
Lead Sponsor:
Medipol University
Conditions:
Copd
Eligibility:
All Genders
40-78 years
Phase:
NA
Brief Summary
Patients with chronic obstructive pulmonary disease (COPD) classified by a pulmonologist in accordance with the GOLD criteria will be randomly divided into 2 groups. The first group (n = 20) was acco...
Detailed Description
Determination of application groups: Patients with chronic obstructive pulmonary disease (COPD) classified by a pulmonologist in accordance with the GOLD criteria will be randomly divided into 2 group...
Eligibility Criteria
Inclusion
- Being diagnosed with mild to severe COPD according to GOLD criteria in the age range of 40-78
- No drug change for at least 30 days
- Not participating in a structured activity program for at least six months
- Have the ability to cooperate.
Exclusion
- Presence of any pathology that limits physical activity performance
- Presence of severe or unstable heart disease
- Presence of peripheral artery disease
- Being in an exacerbation period of the disease
- Presence of another active disease (rheumatic, oncological, traumatic etc.)
- Any neurological or orthopedic disease that prevents exercise
Key Trial Info
Start Date :
August 19 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 25 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04521959
Start Date
August 19 2020
End Date
May 25 2021
Last Update
April 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karabük Üniversitesi Araştırma Hastanesi Göğüs Hastalıkları Kliniği
Karabük, Karabük Province, Turkey (Türkiye), 78600